Search Results
Dec 23, 2025, 18:55 ET Halper Sadeh LLC Encourages UDMY, ALEX, UBFO, MRSN Shareholders to Contact the Firm to Discuss Their Rights
multimedia:https://www.prnewswire.com/news-releases/halper-sadeh-llc-encourages-udmy-alex-ubfo-mrsn-shareholders-to-contact-the-firm-to-discuss-their-rights-302648973.htmlSOURCE
More news about: Halper Sadeh LLP
Dec 17, 2025, 12:06 ET Halper Sadeh LLC Encourages MRSN, CDTX, RYI Shareholders to Contact the Firm to Discuss Their Rights
multimedia:https://www.prnewswire.com/news-releases/halper-sadeh-llc-encourages-mrsn-cdtx-ryi-shareholders-to-contact-the-firm-to-discuss-their-rights-302644880.htmlSOURCE
More news about: Halper Sadeh LLP
Dec 16, 2025, 11:31 ET Shareholder Alert: The Ademi Firm continues to investigate whether Mersana Therapeutics Inc. is obtaining a Fair Price for its Public Shareholders
MILWAUKEE, Dec. 16, 2025 /PRNewswire/ -- The Ademi Firm continues to investigate Mersana (NASDAQ: MRSN) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with Day One Biopharmaceuticals.
More news about: Ademi LLP
Dec 12, 2025, 16:42 ET Mersana Therapeutics Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Mersana Therapeutics, Inc. - MRSN
Mersana Therapeutics, Inc. (NasdaqGS: MRSN) to Day One Biopharmaceuticals, Inc. Under the terms of the proposed transaction, shareholders of Mersana will receive $25.00 per share in cash plus
More news about: Kahn Swick & Foti, LLC
Dec 08, 2025, 14:40 ET $HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--SMLR, MRSN, CDTX, and RYI
MRSN) related to its sale to Day One Biopharmaceuticals, Inc. Under the terms of the proposed transaction, Mersana shareholders will receive $25.00
More news about: Monteverde & Associates PC
Nov 28, 2025, 12:41 ET Halper Sadeh LLC Encourages SEMR, EXAS, MRSN Shareholders to Contact the Firm to Discuss Their Rights
multimedia:https://www.prnewswire.com/news-releases/halper-sadeh-llc-encourages-semr-exas-mrsn-shareholders-to-contact-the-firm-to-discuss-their-rights-302628094.htmlSOURCE
More news about: Halper Sadeh LLP
Nov 27, 2025, 23:11 ET HAPPY THANKSGIVING AND INVESTOR ALERT: The M&A Class Action Firm Continues to Investigate the Merger - EXAS, SEE, CDTX, and MRSN
MRSN) related to its sale to Day One Biopharmaceuticals, Inc. Under the terms of the proposed transaction, Mersana shareholders will receive $25.00
More news about: Monteverde & Associates PC
Nov 17, 2025, 12:00 ET Halper Sadeh LLC Encourages RPTX, SEE, CDTX, MRSN Shareholders to Contact the Firm to Discuss Their Rights
multimedia:https://www.prnewswire.com/news-releases/halper-sadeh-llc-encourages-rptx-see-cdtx-mrsn-shareholders-to-contact-the-firm-to-discuss-their-rights-302617222.html
More news about: Halper Sadeh LLP
Nov 14, 2025, 15:19 ET Halper Sadeh LLC Encourages CDTX, MRSN, HOLX Shareholders to Contact the Firm to Discuss Their Rights
multimedia:https://www.prnewswire.com/news-releases/halper-sadeh-llc-encourages-cdtx-mrsn-holx-shareholders-to-contact-the-firm-to-discuss-their-rights-302615955.html
More news about: Halper Sadeh LLP
Nov 13, 2025, 11:35 ET Shareholder Alert: The Ademi Firm investigates whether Mersana Therapeutics Inc. is obtaining a Fair Price for its Public Shareholders
MILWAUKEE, Nov. 13, 2025 /PRNewswire/ -- The Ademi Firm is investigating Mersana (NASDAQ: MRSN) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with Day One Biopharmaceuticals.
More news about: Ademi LLP